![](/-/media/images/experience-feature-images/2018/02/cvc_capital.jpg?rev=e6f060f15b6f4ac6888fcfdf4c56600a&la=en&h=287&w=548&hash=92650002C9F269DC4E47E156833848C2)
CVC Capital Partners acquires Teva's International Women's Health assets for $703 million
Client(s) CVC Capital Partners Limited
Jones Day advised CVC Capital Partners in its $703 million acquisition of Teva Pharmaceutical Industries Ltd's International (non-US), Women's Health assets.